10X Genomics Inc
NASDAQ:TXG
10X Genomics Inc
NASDAQ:TXG
Price:
21.2
USD
-1.49%
Market Closed
Market Cap:
$2.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
K
|
Keystone Realtors Ltd
NSE:RUSTOMJEE
|
IN |
|
Austal Ltd
ASX:ASB
|
AU |
|
Pembina Pipeline Corp
TSX:PPL
|
CA |
|
L
|
Land and Houses PCL
SET:LH
|
TH |
|
H
|
Humana Inc
SWB:HUM
|
US |
|
NN Group NV
AEX:NN
|
NL |
|
Fleetpartners Group Ltd
ASX:FPR
|
AU |
Wall St Price Targets
TXG Price Targets Summary
10X Genomics Inc
10X Genomics Inc
Wall Street analysts forecast TXG stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TXG is 25.74 USD with a low forecast of 20.2 USD and a high forecast of 33.6 USD.
Lowest Forecast
Price Target
20.2
USD
5% Downside
Average Forecast
Price Target
25.74
USD
21% Upside
Highest Forecast
Price Target
33.6
USD
58% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TXG's stock price target?
Price Target
25.74
USD
25.74
USD
According to Wall Street analysts, the average 1-year price target for TXG is 25.74 USD with a low forecast of 20.2 USD and a high forecast of 33.6 USD.
What is the Revenue forecast for 10X Genomics Inc?
Projected CAGR
10%
10%
Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 7 years is 10%.
